EichorEICHOR
Study identifier: NCT06174987 Synced from ClinicalTrials.gov · August 05, 2026
● Recruiting

A Study to Provide Continued Access to and Assess Long-Term Safety of the Study Drug(s)

Condition: Advanced Cancer · Metastatic Cancer  ·  Sponsor: Daiichi Sankyo

PhasePhase 3
Planned participants50
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This open-label, multicenter, rollover study will provide continued treatment for participants deriving benefit from different therapies received in studies sponsored by Daiichi Sankyo, Inc. (DS) or DS/Astra Zeneca (AZ)-sponsored study (eg. DS8201-A-J101, DS8201-A-U201, DS8201-A-U204, DS8201-A-U207, DS8201-A-U303).

This description comes directly from the study's public registry record.

Talk to the study team

Daiichi Sankyo Contact for Clinical Trial Information  ·  908-992-6400  ·  CTRinfo@dsi.com

Always discuss trial participation with your own doctor first.

Locations (28)

Miami Cancer InstituteMiami, Florida, United StatesRecruiting
Duke University - Trent CenterDurham, North Carolina, United StatesRecruiting
Flinders Medical CenterBedford Park, AustraliaActive Not Recruiting
Monash Medical CenterMelbourne, AustraliaWithdrawn
Grand Hôpital de CharleroiCharleroi, BelgiumRecruiting
Instituto AericasRio de Janeiro, BrazilNot Yet Recruiting
A.C. Camargo Cancer CenterSão Paulo, BrazilNot Yet Recruiting
IBCC Nucleo de Pequisa e EnsinoSão Paulo, BrazilNot Yet Recruiting
Institut Gustave RoussyVillejuif, FranceRecruiting
Rabin Medical CenterPetah Tikva, IsraelActive Not Recruiting
Ospedale San RaffaeleMilan, ItalyRecruiting
Istituto Nazionale Tumori Fondazione G. PascaleNaples, ItalyWithdrawn

+ 16 more locations — full list on the registry record.

Follow this study

Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.

We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →